Pharmaceutical Drugs
FDA Needs Clear Guidelines
Pharmaceutical companies might stop developing treatments for diseases like diabetes or obesity if clearer guidelines are not given from the FDA said Christopher Viehbacher – chairman of the board of Pharmaceutical Research and Manufacturers of America. Pharmaceutical companies are having a difficult time predicting how the Food and Drug Administration weighs the risks and benefits for medications that are commonly taken. Pharmaceutical companies may focusing on cancer treatments, since both patients and the FDA are more open to accepting serious adverse events for medications that may potentially save lives.
